Chongying Jin

机构：Sir Run Run Shaw Hospital, Precision for Medicine (United States), Zhejiang University

发表论文 28 篇 · 总被引 440 次 · h-index 13

代表论文

• A Randomized Trial Comparing the NeoVas Sirolimus-Eluting Bioresorbable Scaffold and Metallic Everolimus-Eluting Stents (2018 · JACC: Cardiovascular Interventions · 被引 61)
• Leptin confers protection against TNF-α-induced apoptosis in rat cardiomyocytes (2014 · Biochemical and Biophysical Research Communications · 被引 29)
• Optical coherence tomography enables more accurate detection of functionally significant intermediate non-left main coronary artery stenoses than intravascular ultrasound: A meta-analysis of 6919 patients and 7537 lesions (2019 · International Journal of Cardiology · 被引 26)
• Theaflavin 3,3′‐digallate reverses the downregulation of connexin 43 and autophagy induced by high glucose via AMPK activation in cardiomyocytes (2019 · Journal of Cellular Physiology · 被引 26)
• P38 MAPK/miR‐1 are involved in the protective effect of EGCG in high glucose‐induced Cx43 downregulation in neonatal rat cardiomyocytes (2016 · Cell Biology International · 被引 22)
• Clinical and multimodality imaging results at 6 months of a bioresorbable sirolimus-eluting scaffold for patients with single de novo coronary artery lesions: the NeoVas first-in-man trial (2016 · EuroIntervention · 被引 20)